(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEOANTIGENID

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEOANTIGENID

ST13

US500000090080382

Class

42, 44

Filing

90080382

Registration

6405467

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

06/29/2026

Trademark type

Word

Nice classes

42, 44

Filing date

07/29/2020

Registration date

06/29/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/29/2021

Last transaction

06/29/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

First use anywhere

02/08/2018

First use in commerce

02/08/2018

Drawing code

4

Owner type

03

Owner location

Menlo Park, CA, US

Examiner

EVANKO, PATRICIA MALESARDI

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Personalis, Inc.

Representatives

Laura C. Miller KILPATRICK TOWNSEND & STOCKTON LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing genome sequencingdata analysis and interpretationassay development and preparingamplifyinglabelingdetectinganalyzing and sequencing nucleic acids and other biological moleculesresearch and design relating theretoall in the field of bioinformaticsgenomics and gene expression research and development

Class 44

Analysis of cellsamino acidstissuesgene expressionsgene sequencesgenome annotationtranscriptome characterizationgenome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressionsgene and genome sequencesgenome interaction and annotationtranscriptome analysis and characterizationgenome mapping for medical diagnosis and treatment

Publications

History of USPTO decisions and trademark events.

14 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/29/2026

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

06/29/2021

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/25/2021

ALIE

ASSIGNED TO LIE

05/25/2021

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

05/24/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/07/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/07/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/07/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/23/2020

GNRT

NON-FINAL ACTION E-MAILED

11/23/2020

CNRT

NON-FINAL ACTION WRITTEN

11/23/2020

DOCK

ASSIGNED TO EXAMINER

11/17/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/27/2020

NWAP

NEW APPLICATION ENTERED

08/01/2020

Continuous trademark protection

Get notified about every new filing that threatens NEOANTIGENID or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.